Dipeptidyl Peptidase
Read More about this categoryShow Less
Dipeptidyl Peptidase (DPP) is an antigenic enzyme expressed on the surface of most cell types and is associated with immune regulation,signal transduction and apoptosis. DPP is an intrinsic membrane glycoprotein and a serine exopeptidase that cleaves X-proline dipeptides from the N-terminus of polypeptides. The substrates of DPP are proline-containing peptides and include growth factors, chemokines, neuropeptides, and vasoactive peptides. DPP plays a major role in glucose metabolism. DPP is responsible for the degradation of incretins such as GLP-1. Furthermore, DPP appears to work as a suppressor in the development of cancer and tumours. DPP plays an important role in tumor biology, and is useful as a marker for various cancers, with its levels either on the cell surface or in the serum increased in some neoplasms and decreased in others.
Products Related to Dipeptidyl Peptidase(55)
- GA22366H-Glu(Tyr-OH)-OHCAS: 7432-23-7Purity: >98.00%
H-Glu(Tyr-OH)-OH is a dipeptide composed of glutamic acid (Glu) and tyrosine (Tyr). Its chemical name is L-glutamyl-L-tyrosine, with the molecular formula C₁₄H₁₈N₂O₆ and a molecular weight of approximately 310.3. H-Glu(Tyr-OH)-OH is a competitive inhibitor of dipeptidyl peptidase-IV (DPP-IV) (IC₅₀ = 6.77mM) and may have potential for the treatment of type II diabetes.
- GA22410H-Gly-Arg-AMCCAS: 65147-19-5Purity: >98%
H-Gly-Arg-AMC is a fluorogenic substrate for cathepsin C, with maximum excitation/emission wavelengths of 340-360/440-460nm.
- GC10018Talabostat mesylateCAS: 150080-09-4Purity: >99.00%
Talabostat (PT100) is an orally active and non-selective inhibitor of dipeptidyl peptidase IV (DPP-IV) ( IC 50 < 4 nM; K i = 0.18 nM) and the first clinical inhibitor of fibroblast activation protein (FAP) ( IC 50 = 560 nM), inhibiting DPP 8/9 ( IC 50 = 4/11 nM; K i = 1.5/0.76 nM), prolyl endopeptidase (QPP) (IC50= 310 nM), DPP2, and other DASH family enzymes.
- GC12360UAMC 00039 dihydrochlorideCAS: 697797-51-6Purity: >99.50%
dipeptidyl peptidase II (DPP-II) inhibitor
- GC12895SaxagliptinCAS: 361442-04-8Purity: >99.50%
Saxagliptin is a highly potent dipeptidyl peptidase-4 (DPP-4) inhibitor that regulates blood glucose by selectively inhibiting the DPP-4 enzyme, thereby elevating levels of endogenous glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP).
- GC30877DPP-IV-IN-2CAS: 136259-18-2Purity: >98.00%
DPP-IV-IN-2 is an inhibitor of both dipeptidyl peptidase IV (DPIV) and DP8/9 with IC50s of 0.1 and 0.95 μM, respectively.
- GC31317Sitagliptin (MK0431)CAS: 486460-32-6Purity: >99.50%
Sitagliptin (MK0431) is an oral and highly selective Dipeptidyl peptidase-4 (DPP-4) inhibitor with an IC 50 of 18nM.
- GC31333Teneligliptin (MP-513)CAS: 760937-92-6Purity: >99.50%
Teneligliptin (MP-513) (MP-513) is a potent, orally available, competitive, and long-lasting DPP-4 inhibitor.
- GC31341Anagliptin (SK-0403)CAS: 739366-20-2Purity: >98%
Anagliptin (SK-0403) (SK-0403) is a highly selective, potent, orally active inhibitor of dipeptidyl peptidase 4 (DPP-4), with an IC50 of 3.8 nM, and less selective at DPP-8 and DDP-9 with IC50s of 68 nM and 60 nM, respectively.
- GC31414Diprotin A TFA (Ile-Pro-Pro (TFA))CAS: 209248-71-5Purity: >98.50%
Diprotin A TFA (Ile-Pro-Pro (TFA)) (Ile-Pro-Ile TFA) is an inhibitor of dipeptidyl peptidase IV (DPP-IV).
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GA22366 | H-Glu(Tyr-OH)-OH | 7432-23-7 | >98.00% | |
H-Glu(Tyr-OH)-OH is a dipeptide composed of glutamic acid (Glu) and tyrosine (Tyr). Its chemical name is L-glutamyl-L-tyrosine, with the molecular formula C₁₄H₁₈N₂O₆ and a molecular weight of approximately 310.3. H-Glu(Tyr-OH)-OH is a competitive inhibitor of dipeptidyl peptidase-IV (DPP-IV) (IC₅₀ = 6.77mM) and may have potential for the treatment of type II diabetes. | ||||
| GA22410 | H-Gly-Arg-AMC | 65147-19-5 | >98% | |
H-Gly-Arg-AMC is a fluorogenic substrate for cathepsin C, with maximum excitation/emission wavelengths of 340-360/440-460nm. | ||||
| GC10018 | Talabostat mesylate | 150080-09-4 | >99.00% | |
Talabostat (PT100) is an orally active and non-selective inhibitor of dipeptidyl peptidase IV (DPP-IV) ( IC 50 < 4 nM; K i = 0.18 nM) and the first clinical inhibitor of fibroblast activation protein (FAP) ( IC 50 = 560 nM), inhibiting DPP 8/9 ( IC 50 = 4/11 nM; K i = 1.5/0.76 nM), prolyl endopeptidase (QPP) (IC50= 310 nM), DPP2, and other DASH family enzymes. | ||||
| GC10091 | Nateglinide | 105816-04-4 | >99.50% | |
Insulin secretagog agent | ||||
| GC10171 | Puromycin aminonucleoside | 58-60-6 | >98.00% | |
A glomerular epithelial cell toxin | ||||
| GC10298 | Sitagliptin phosphate monohydrate | 654671-77-9 | >99.50% | |
| GC12235 | Sitagliptin (phosphate) | 654671-78-0 | >98.00% | |
DPP-4 inhibitor | ||||
| GC12360 | UAMC 00039 dihydrochloride | 697797-51-6 | >99.50% | |
dipeptidyl peptidase II (DPP-II) inhibitor | ||||
| GC12895 | Saxagliptin | 361442-04-8 | >99.50% | |
Saxagliptin is a highly potent dipeptidyl peptidase-4 (DPP-4) inhibitor that regulates blood glucose by selectively inhibiting the DPP-4 enzyme, thereby elevating levels of endogenous glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). | ||||
| GC13949 | Alogliptin Benzoate | 850649-62-6 | >99.50% | |
A DPP-4 inhibitor | ||||
| GC14827 | Linagliptin (BI-1356) | 668270-12-0 | >99.50% | |
A potent DPP-4 inhibitor | ||||
| GC15130 | Alogliptin (SYR-322) | 850649-61-5 | >99.00% | |
| GC15576 | Teneligliptin hydrobromide | 906093-29-6 | >99.50% | |
A DPP-4 inhibitor | ||||
| GC16613 | Trelagliptin | 865759-25-7 | >99.50% | |
A DDP-4 inhibitor | ||||
| GC16733 | Vildagliptin (LAF-237) | 274901-16-5 | >98.00% | |
A DPP-4 inhibitor | ||||
| GC17012 | MK3102 | 1226781-44-7 | >99.00% | |
MK3102 (Omarigliptin) is a novel once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor (IC50: 2.2 nM) developed for the treatment of type 2 diabetes. | ||||
| GC17479 | Trelagliptin succinate | 1029877-94-8 | >99.50% | |
A DDP-4 inhibitor | ||||
| GC19052 | AZD7986 | 1802148-05-5 | >99.00% | |
AZD7986 (AZD7986) is an oral dipeptidyl peptidase 1 (DPP1) inhibitor with pIC50s of 6.85, 7.6, 7.7, 7.8, and 7.8 in human, mouse, rat, dog and rabbit, respectively. | ||||
| GC19120 | DBPR108 | 1186426-66-3 | >99.50% | |
DBPR108 is a potent, selective, and orally bioavailable dipeptide-derived inhibitor of DPP4 with IC50 of 15 nM; no inhibition on DDP8 and DPP9. | ||||
| GC30877 | DPP-IV-IN-2 | 136259-18-2 | >98.00% | |
DPP-IV-IN-2 is an inhibitor of both dipeptidyl peptidase IV (DPIV) and DP8/9 with IC50s of 0.1 and 0.95 μM, respectively. | ||||
| GC31317 | Sitagliptin (MK0431) | 486460-32-6 | >99.50% | |
Sitagliptin (MK0431) is an oral and highly selective Dipeptidyl peptidase-4 (DPP-4) inhibitor with an IC 50 of 18nM. | ||||
| GC31333 | Teneligliptin (MP-513) | 760937-92-6 | >99.50% | |
Teneligliptin (MP-513) (MP-513) is a potent, orally available, competitive, and long-lasting DPP-4 inhibitor. | ||||
| GC31341 | Anagliptin (SK-0403) | 739366-20-2 | >98% | |
Anagliptin (SK-0403) (SK-0403) is a highly selective, potent, orally active inhibitor of dipeptidyl peptidase 4 (DPP-4), with an IC50 of 3.8 nM, and less selective at DPP-8 and DDP-9 with IC50s of 68 nM and 60 nM, respectively. | ||||
| GC31414 | Diprotin A TFA (Ile-Pro-Pro (TFA)) | 209248-71-5 | >98.50% | |
Diprotin A TFA (Ile-Pro-Pro (TFA)) (Ile-Pro-Ile TFA) is an inhibitor of dipeptidyl peptidase IV (DPP-IV). | ||||
